Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 27 Artikel )

21.03.2019 | Review | Ausgabe 2/2019

Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients

Alfredo Torres, Jeremy L. Ramdial, Luis E. Aguirre, Reshma Mahtani, Charles L. Vogel

24.04.2019 | Review | Ausgabe 2/2019

Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy

Maysa M. Abu-Khalaf, Anton Safonov, Jamie Stratton, Shiyi Wang, Christos Hatzis, Esther Park, Lajos Pusztai, Cary P. Gross, Raymond Russell

20.04.2019 | Preclinical study | Ausgabe 2/2019 Open Access

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer

S. Speransky, P. Serafini, J. Caroli, S. Bicciato, M. E. Lippman, N. H. Bishopric

20.04.2019 | Preclinical study | Ausgabe 2/2019

Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer

Chunyi Gao, Xiaoyu Yuan, Zhenglin Jiang, Deqiang Gan, Lingzhi Ding, Yechao Sun, Jiamin Zhou, Lihua Xu, Yifei Liu, Guohua Wang

19.04.2019 | Clinical Trial | Ausgabe 2/2019

Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)

Jennifer R. Bellon, Hao Guo, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew Ellis, Antonio C. Wolff, Lisa A. Carey, Beth A. Overmoyer, Ann H. Partridge, Clifford A. Hudis, Ian Krop, Harold J. Burstein, Eric P. Winer, Sara M. Tolaney

22.04.2019 | Clinical trial | Ausgabe 2/2019

Comparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgery

George Boundouki, Joseph Ryan Wong Sik Hee, Natalie Croghan, Katie Stocking, Andrew Pieri, Adam Critchley, Cliona C. Kirwan, James R. Harvey

23.04.2019 | Clinical trial | Ausgabe 2/2019

Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases

Maria J. Sambade, Grace Prince, Allison M. Deal, Dimitri Trembath, Megan McKee, Amy Garrett, Kevin Keith, Juanita Ramirez, Bentley Midkiff, Kimberly Blackwell, Sarah Sammons, Jose Pablo Leone, Adam Brufsky, Aki Morikawa, Edi Brogi, Andrew Seidman, Matthew Ewend, Lisa A. Carey, Stergios J. Moschos, Ronald L. Hamilton, Benjamin Vincent, Carey Anders

23.04.2019 | Clinical trial | Ausgabe 2/2019

Breast desmoid tumor management in France: toward a new strategy

Ludwig Duazo-Cassin, Sophie Le Guellec, Amélie Lusque, Elodie Chantalat, Marick Laé, Philippe Terrier, Jean-Michel Coindre, Bérénice Boulet, Morwenn Le Boulc’h, Dimitri Gangloff, Thomas Meresse, Benoit Chaput, Amal Al Ali, Françoise Rimareix, Sylvie Bonvalot, Charlotte Vaysse

24.04.2019 | Clinical trial | Ausgabe 2/2019

Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case–control analysis

Maoli Wang, Hongliang Chen, Kejin Wu, Ang Ding, Peng Zhang, Mingdi Zhang

25.04.2019 | Clinical trial | Ausgabe 2/2019

The impact of communication style on patient satisfaction

Amelia A. Trant, Borbala Szekely, Sarah S. Mougalian, Michael P. DiGiovanna, Tara Sanft, Erin Hofstatter, Andrea Silber, Kerin B. Adelson, Anees Chagpar, Brigid Killelea, Nina Horowitz, Donald Lannin, Tristen Park, Michelle Corso, Gineesha Abraham, Karen Pollard-Murphy, Tracy Sturrock, Elspeth Knill-Selby, Ashley Western, Camille Servodidio, Marios Konstantinos Tasoulis, Barbara Healy, Christos Hatzis, Lajos Pusztai

26.04.2019 | Clinical trial | Ausgabe 2/2019

Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311

Stephen. P. Ackland, V. Gebski, N. Zdenkowski, A. Wilson, M. Green, S. Tees, H. Dhillon, G. Van Hazel, J. Levi, R. J. Simes, J. F. Forbes, A. S. Coates, for Breast Cancer Trials Ltd (formerly known as the Australia and New Zealand Breast Cancer Trials Group)

27.04.2019 | Clinical trial | Ausgabe 2/2019 Open Access

The influence of neoadjuvant chemotherapy on complications of immediate DIEP flap breast reconstructions

J. Beugels, J. L. W. Meijvogel, S. M. H. Tuinder, V. C. G. Tjan-Heijnen, E. M. Heuts, A. Piatkowski, R. R. W. J. van der Hulst

30.04.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Ivana Sestak, Miguel Martín, Peter Dubsky, Ralf Kronenwett, Federico Rojo, Jack Cuzick, Martin Filipits, Amparo Ruiz, William Gradishar, Hatem Soliman, Lee Schwartzberg, Richard Buus, Dominik Hlauschek, Alvaro Rodríguez-Lescure, Michael Gnant

30.04.2019 | Clinical trial | Ausgabe 2/2019

Circulating adipose stromal cells as a response biomarker in phase II energy balance trials of obese breast cancer survivors and high-risk women

Hailey A. Baker, Carol J. Fabian, Richard C. Hastings, Dan A. Dixon, Jennifer L. Nydegger, Teresa A. Phillips, Kandy R. Powers, Bruce F. Kimler

30.04.2019 | Clinical trial | Ausgabe 2/2019

Establishing physical activity in breast cancer: self-report versus activity tracker

Chad W. Wagoner, Seul K. Choi, Allison M. Deal, Jordan T. Lee, William A. Wood, Hyman B. Muss, Kirsten A. Nyrop

20.04.2019 | Epidemiology | Ausgabe 2/2019

Does every woman presenting with malignant calcifications require a post lumpectomy mammogram?

Hálio Rodrigues-Duarte, Thiemo J. A. van Nijnatten, Tatiana Khoury, Hiram Cody, Stefanie Jacobs, Maxine S. Jochelson

22.04.2019 | Epidemiology | Ausgabe 2/2019

Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa

Catherine Schairer, Ahmed Hablas, Ibrahim AbdelBar Seif Eldein, Rabab Gaafar, Henda Rais, Amel Mezlini, Farhat Ben Ayed, Wided Ben Ayoub, Abdellatif Benider, Ali Tahri, Mouna Khouchani, Dalia Aboulazm, Mehdi Karkouri, Saad Eissa, Ruth M. Pfeiffer, Shahinaz M. Gadalla, Sandra M. Swain, Sofia D. Merajver, Linda Morris Brown, Amr S. Soliman

24.04.2019 | Epidemiology | Ausgabe 2/2019

Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study

Hak Min Lee, Bo Wook Kim, Seho Park, Sungmin Park, Jeon Eon Lee, Young Jin Choi, Sung Yong Kim, Sang Uk Woo, Hyun Jo Youn, Ilkyun Lee

20.03.2019 | Epidemiology | Ausgabe 2/2019

Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Leticia Varella, Akaolisa Samuel Eziokwu, Xuefei Jia, Megan Kruse, Halle C. F. Moore, George Thomas Budd, Jame Abraham, Alberto J. Montero

25.04.2019 | Epidemiology | Ausgabe 2/2019

Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes

Anna Weiss, Heather Lin, Gildy V. Babiera, Isabelle Bedrosian, Simona F. Shaitelman, Yu Shen, Henry M. Kuerer, Elizabeth A. Mittendorf, Abigail S. Caudle, Kelly K. Hunt, Rosa F. Hwang

26.04.2019 | Epidemiology | Ausgabe 2/2019

Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer

Jason Rotter, Lauren Wilson, Melissa A. Greiner, Craig E. Pollack, Michaela Dinan

26.04.2019 | Epidemiology | Ausgabe 2/2019

Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients

Jung Youn Kim, Dae-Won Lee, Kyung-Hun Lee, Ahrum Min, Han Suk Ryu, Han-Byoel Lee, Hyeong-Gon Moon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im, Sukil Kim

26.04.2019 | Epidemiology | Ausgabe 2/2019

Racial disparities in surveillance mammography among older breast cancer survivors

Jimmitti Teysir, Nana Gegechkori, Juan P. Wisnivesky, Jenny J. Lin

02.05.2019 | Epidemiology | Ausgabe 2/2019

Noncompliance with palliative systemic therapy in patients with distant metastatic breast cancer: a blind spot for oncologists?

Constanze Elfgen, Giacomo Montagna, Seraina Margaretha Schmid, Walter Bierbauer, Uwe Güth

23.04.2019 | Letter to the Editor | Ausgabe 2/2019

Oral or intravenous vinorelbine plus capecitabine in heavily pretreated HER2 negative metastatic breast cancer; similar effect or quality of life?

Kadri Altundag

25.04.2019 | Letter to the Editor | Ausgabe 2/2019

Classifying sarcopenia: using median value or cut-off values?

Onur Bas, Omer Dizdar

31.05.2019 | Correction | Ausgabe 2/2019 Open Access

Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

Christoph J. Rageth, Elizabeth A. M. O’Flynn, Katja Pinker, Rahel A. Kubik-Huch, Alexander Mundinger, Thomas Decker, Christoph Tausch, Florian Dammann, Pascal A. Baltzer, Eva Maria Fallenberg, Maria P. Foschini, Sophie Dellas, Michael Knauer, Caroline Malhaire, Martin Sonnenschein, Andreas Boos, Elisabeth Morris, Zsuzsanna Varga

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.